Package 24478-110-01
Brand: dyanavel xr
Generic: amphetaminePackage Facts
Identity
Package NDC
24478-110-01
Digits Only
2447811001
Product NDC
24478-110
Description
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (24478-110-01)
Marketing
Marketing Status
Brand
dyanavel xr
Generic
amphetamine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "32c90701-fe4a-4d5a-b3bb-e9ccf0416ece", "openfda": {"nui": ["N0000175739", "N0000175729"], "upc": ["0324478102029", "0324478108014", "0324478110017", "0324478109011"], "unii": ["CK833KGX7E"], "rxcui": ["1720586", "1720592", "2585460", "2585461", "2585462", "2585465", "2585468", "2585471", "2585473", "2585476"], "spl_set_id": ["ae304b29-0b40-40ec-ad0d-76b742d4a9b9"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "manufacturer_name": ["NextWave Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (24478-110-01)", "package_ndc": "24478-110-01", "marketing_start_date": "20220801"}], "brand_name": "DYANAVEL XR", "product_id": "24478-110_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "24478-110", "dea_schedule": "CII", "generic_name": "amphetamine", "labeler_name": "NextWave Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DYANAVEL XR", "active_ingredients": [{"name": "AMPHETAMINE", "strength": "20 mg/1"}], "application_number": "NDA210526", "marketing_category": "NDA", "marketing_start_date": "20211104", "listing_expiration_date": "20271231"}